RESEARCH ARTICLE


Impact of the L-arginine-Nitric Oxide Pathway and Oxidative Stress on the Pathogenesis of the Metabolic Syndrome



C.R Assumpção, T.M.C Brunini, C Matsuura, A.C Resende , A.C Mendes-Ribeiro*


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 1352
Abstract HTML Views: 816
PDF Downloads: 344
Total Views/Downloads: 2512
Unique Statistics:

Full-Text HTML Views: 707
Abstract HTML Views: 481
PDF Downloads: 257
Total Views/Downloads: 1445



Creative Commons License
© Assumpção et al.; Licensee Bentham Open.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.

* Address correspondence to this author at the Departamento de Farmacologia e Psicobiologia, Instituto de Biologia – Centro Biomédico, Universidade do Estado do Rio de Janeiro Rio de Janeiro, 20551–030, Brazil; Tel∕Fax 00 55 21 2249 5823; E-mail: cribeiro@physiol.ox.ac.uk


Abstract

The discovery of the physiological roles of nitric oxide has revolutionized the understanding of regulation of vascular tone, platelet adhesion and aggregation, and immune activation. Perhaps the most intriguing aspect of nitric oxide (NO) is that it is a gas that, in the absence of receptors, can regulate both normal physiological events and mediate cytotoxicity under pathological conditions. NO is produced from L-arginine by NO synthases (NOS), yielding L-citrulline and NO. The regulation of L-arginine pathway activity occurs at the level of NO production. The metabolic syndrome is a cluster of insulin resistance, elevated blood pressure, and atherogenic dyslipidemia, a common basis of cardiovascular disease. It occurs in genetically susceptible individuals with environmental influences and has serious economic and social consequences. Pharmacological and non-pharmacological therapies should be individualized and targeted to normalize its alterations of blood pressure, HDL cholesterol, triglycerides and glucose values. Despite the increasing prevalence of the metabolic syndrome in the last decades, there has been little progress in the understanding of the precise mechanisms involved in the pathogenesis of this syndrome and its complications. Emerging evidence is available that NO, inflammation and oxidative stress play important roles in the physiopathology of this syndrome. This review summarizes and evaluates the participation of the L-arginine-NO pathway and oxidative stress in the physiopathology of the metabolic syndrome and cardiovascular events at the systemic level, as well as the effects of exercise on this syndrome.

Keywords: Nitric oxide, L-arginine, metabolic syndrome, blood cells, endothelium.